R 115866 clinical trials
Also written Talarozole, Rambazole and R115866.
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 2004
How each study uses R 115866 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
4 studies that test it; most in 2004 (2)
| Year | Studies |
|---|---|
| 2004 | 2 |
| 2006 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 4 · Other 0
Often tested with
Tested in the same studies.
Related medicines
As reviewed, each with the page that says it.
- One of Aromatase inhibitors source
Studies
Open first, then newest update. How each study uses R 115866 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- Dose Ranging Study of the Safety and Efficacy of R115966 in Plaque PsoriasisCompletedPhase 2Stiefel, a GSK CompanyNCT00716144Written as Talarozole
- An Open-Label, Multi-Center Trial in the Treatment of Subjects With Moderate to Severe Plaque Type PsoriasisCompletedPhase 2Stiefel, a GSK CompanyNCT00725348Written as Talarozole
- An Open Label Trial to Assess the Safety and Efficacy of Oral R115866 in the Treatment Facial AcneCompletedPhase 2Stiefel, a GSK CompanyNCT00725439Written as Talarozole
- Study on Anti-inflammatory Effects of Topical R115866 GelCompletedPhase 1Stiefel, a GSK CompanyNCT00719121Written as Talarozole
Codes
What other systems call R 115866 · ClinicalTrials.gg INT004225
- MeSH (NLM) C406527R 115866Confirmed ClinicalTrials.gov, NLM
- UNII (FDA) XKD9N5CJ6WTALAROZOLEConfirmed FDA, NLM
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C406527 | R 115866 | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | XKD9N5CJ6W | TALAROZOLE | Confirmed FDA, NLM |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.